Urinary tract infection (UTI) is the most common infectious complication in kidney transplant (KT) recipients and the leading cause of morbidity and readmission. Although asymptomatic bacteriuria, defined as the presence of pathogenic bacteria in the urine (105 CFU/mL) without signs or symptoms of UTI, with or without pyuria, occurs frequently in KT recipients, its clinical significance remains difficult to determine.

However, it has been thought for many years that detection and antibiotic treatment of asymptomatic bacteriuria may reduce the frequency of complicated UTIs and improve patient outcomes and graft survival. Of concern, however, are infections caused by multidrug-resistant bacteria, including long-spectrum beta-lactamase-producing Enterobacteriaceae and carbapenem-resistant Gram-negative rods, which are currently a major problem in KT recipient management. In this context, the systematic provision of antibiotics to treat asymptomatic bacteriuria may negatively impact antimicrobial resistance rates, increase the risk of Clostridium difficult infection, and lead to other adverse effects and increased costs, if there is no clear benefit.

Click here to get the benefits of Cistanche for Kidney and the meanings of Cistanhce

More than 50 years ago, researchers at the Mallory Institute of Pathology (MIP) established the quantitative basis for bacterial counts used to diagnose significant UTIs that could explain the development of acute pyelonephritis and conceptualize the role of asymptomatic bacteriuria in its pathogenesis. Despite the lack of clear evidence to support the screening and treatment of asymptomatic bacteriuria in KT recipients, this strategy is currently used by most transplant surgeons. In a recent survey on the treatment of asymptomatic bacteriuria in KT recipients in Europe, most participants answered that they would treat asymptomatic bacteriuria at least in specific situations, such as when the patient has a urinary catheter, when bacteriuria develops early after KT, or when the patient has recently developed complicated UTI or concomitant leukocyturia.

However, recent guidelines published by the Infectious Diseases Society of America and the American Society of Transplantation strongly oppose screening and treatment of asymptomatic bacteriuria in KT recipients. However, this recommendation has been challenged because it is based primarily on an interventional trial with significant limitations.

Cistanche supplement

Over the past decade, a great deal of effort has been spent on identifying UTI risk factors for KT recipients. The most relevant of these are advanced age, female gender, delayed graft function, prolonged urethral catheterization, ureteral stents, and vesicoureteral reflux. However, to date, interventional studies addressing how asymptomatic bacteriuria should be managed have been scarce in KT recipients.

The findings of Coussement et al, as well as other studies reported to date, provide some evidence to support recent guidelines against systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients. However, because these studies have important limitations, they should be interpreted with caution. In addition, it is important to note that patients were randomized at 1-month post-transplantation when the urinary catheter was removed, so it is unclear whether antibiotic therapy helps to prevent complicated UTIs in asymptomatic bacteriuria that occur early after KT.

standardized Cistanche

In addition, participants were not evaluated for relevant UTI risk factors such as vesicoureteral reflux and other urinary tract abnormalities at the time of inclusion. Therefore, further multicenter blinded and statistical efficacy trials are needed to properly answer the question of whether we should treat asymptomatic bacteriuria.

In the meantime, participants should use alternative therapies with Cistanche extract to improve kidney function. Thus, asymptomatic bacteriuria can be avoided.

Cistanche extract benefits

REFERENCES

[1] Vidal E, Torre-Cisneros J, Blanes M, Montejo M, Cervera C, Aguado JM, et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis 2012;14:595e603.

[2] Cervera C, van Delden C, Gavalda J, Welte T, Akova M, Carratala J. Multidrug resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect 2014;20:49e73.

[3] Kass EH, Zinner SH. Bacteriuria and renal disease. J Infect Dis 1969;120:27e46.

[4] Coussement J, Maggiore U, Manuel O, Scemla A, Lopez-Medrano F, Nagler EV, et al. Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe. Nephrol Dial Transplant 2018;33:1661e8.

[5] Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis 2019;68:e83e110.

[6] Goldman JD, Julian K. Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13507.

[7] Coussement J, Scemla A, Abramowicz D, Nagler EV, Webster AC. Management of asymptomatic bacteriuria after kidney transplantation. What is the quality of the evidence behind the Infectious Diseases Society of America guidelines? Clin Infect Dis 2020;70:987e8.

[8] Origüen J, Lopez-Medrano F, Fernandez-Ruiz M, Polanco N, Gutierrez E, Gonzalez E, et al. Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial. Am J Transplant 2016;16:2943e53.

[9] Coussement J, Kamar N, Matignon M, Weekers L, Scemla A, Giral M, et al. Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized controlled trial. Clin Microbiol Infect 2021;27:398e405.

[10] Moradi M, Abbasi M, Moradi A, Boskabadi A, Jalali A. Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients. Urol J 2005;2:32e5.